About Tivic Health
COMPANY
About Tivic Health
Headquarters: San Francisco Bay Area, CA
Sector: Healthtech, Bioelectronic Medicine
Stage: Commercial
Tivic is a commercial health tech company advancing the field of bioelectronic medicine. Tivic’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures.
Tivic’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications.
Tivic’s first commercial product ClearUP is an FDA approved, award-winning, handheld bioelectronic sinus device. ClearUP is clinically proven, doctor recommended, and is available through online retailers and commercial distributors.
McKinsey & Company estimates that bioelectronic medicine “represents a multibillion dollar opportunity even with modest penetration.”
Users and doctors share their experiences with ClearUP
Key Milestones
-
2016 Q3: Tivic Health was founded
-
2018 Q2: Completed FDA pivotal trial for ClearUP
-
2018 Q3: Received FDA 510(k) for ClearUP
-
2019 Q1: Received FDA’s first clearance for ClearUP
-
2019 Q3: ClearUP began commercial shipment
-
2019 Q4: Received ISO 13485 certification
-
2020 Q1: ClearUP received CE Mark approval
-
2020 Q3: USPTO granted Tivic’s first patents
-
2021 Q1: Received FDA’s second clearance for ClearUP
-
2021 Q2: Over 20,000 lives touched by ClearUP
-
2021 Q2: Bridge financing closed bringing investment to date $13 million
-
2021 Q3: Tivic Health set terms for a $17 million IPO
-
2021 Q4: Tivic Health (“TIVC”) listed on NASDAQ in November
-
2022 Q1: ClearUP named best sinus pain relief by Global Health & Pharma Magazine
-
2022 Q2: Broaden our IP portfolio claims to 96 and initiated the development of a product candidate in migraine
-
2022 Q3: Over 35,000 lives touched by ClearUP
-
2022 Q4: Reduced 40% in cost for ClearUP from initial product
Awards & Recognition
2022
- Most Innovative Sinus Relief Solution from Global Health & Pharma Magazine (GHP)
- Silicon Valley Business Journal Women of Influence, Jennifer Ernst
2021
- Inc. Magazine Top 100 Female Founders
- Top 100 Companies in Healthcare Technology
- Top Women Leaders in Consumer Healthtech
- Fast Company’s 2021 Next Big Things in Tech Awards
- Best Sinus Award from Global Health & Pharma Magazine (GHP)
2020
- Fast Company’s 2020 World Changing Ideas Award, Honorable Mention
- CES Innovation Awards, Honoree
- MedTech Breakthrough Award, Best New Technology Solution
- Last Gadget Standing, Consumer Electronics Show (CES)
- Digital Trends, Editor’s Pick, Best Healthcare Awards
- Innovation & Tech Today, Top 50 Most Innovative Products
2019
- TIME 100 Best Inventions
- MedTech Insight Awards Finalist 2019 - Most Innovative Team
- Techlicious, Top Picks of CES
- Gear Diary, Best of CES
- CES Innovation Awards, Honoree
2018
- Runner-up for Best Clinical Manuscript at Annual Meeting of the American Rhinologic Society
- Gold Electrode Award, Neurotech Leaders Forum
